laurence klotz
University of Toronto
H-index: 94
North America-Canada
Top articles of laurence klotz
MP68-07 PROPORTION OF GLEASON 8-10 PROSTATE CANCER FOUND ON BIOPSY AND TUMOR AGGRESSIVENESS IN MATCHED COHORTS OF MEN IN ASIA AND WESTERN COUNTRIES
The Journal of Urology
2024/5
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy: A survey of specialized physicians
Canadian Urological Association Journal
2024/4/2
‘Spin’in urology non‐randomised studies comparing therapeutic interventions: a temporal analysis
2024/3/20
Wilson Ho
H-Index: 4
Laurence Klotz
H-Index: 55
Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 5-year follow up
2023
Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
BJUI compass
2024/3
Laurence Klotz
H-Index: 55
Using active surveillance for Gleason 7 (3+ 4) prostate cancer: A narrative review
2024
Laurence Klotz
H-Index: 55
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC …
European Journal of Cancer
2023/5/1
Matthew Smith
H-Index: 3
Bertrand Tombal
H-Index: 56
Gerhardt Attard
H-Index: 54
Himisha Beltran
H-Index: 53
Nicola Fossati
H-Index: 39
Mark Frydenberg
H-Index: 37
Rob Jones
H-Index: 20
Laurence Klotz
H-Index: 55
David Matheson
H-Index: 16
Michael J Morris
H-Index: 12
Deborah Mukherji
H-Index: 21
Paul L Nguyen
H-Index: 54
Mark A Rubin
H-Index: 115
Fred Saad
H-Index: 93
Oliver Sartor
H-Index: 56
Nima Sharifi
H-Index: 1
Daniel E Spratt
H-Index: 44
Matthew R Sydes
H-Index: 54
Thomas Zilli
H-Index: 20
MP44-12 mpMRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC TRUS BIOPSY FOR MEN AT RISK FOR PROSTATE CANCER: 2 YEAR FOLLOW UP DATA AND ECONOMIC ANALYSIS
The Journal of Urology
2023/4
Laurence Klotz
H-Index: 55
Joseph Chin
H-Index: 1
MP73-05 PIVOTAL STUDY OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW UP
The Journal of Urology
2023/4
PD30-02 ASSESSING" SPIN" IN UROLOGY RANDOMIZED CONTROLLED TRIALS WITH STATISTICALLY NON-SIGNIFICANT PRIMARY OUTCOMES
The Journal of Urology
2023/4
Increasing trend of utilising active surveillance for Gleason Score 7 (3+ 4) prostate cancer
BJU Int
2023/12
Laurence Klotz
H-Index: 55
Abstract No. 9▪ FEATURED ABSTRACT Pivotal Study of Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation (TULSA) of the Prostate: 4-year Follow-up
Journal of Vascular and Interventional Radiology
2023/3/1
Magnetic Resonance Imaging–Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)
European Urology Oncology
2023/10/12
Multi-parametric MRI-targeted biopsy compared to systematic TRUS biopsy for biopsy-naïve men at risk for prostate cancer: 2 year follow up data and economic analysis
European Urology
2023/2/1
Cardiovascular effects of GnRH antagonists compared with agonists in prostate cancer: a systematic review
2023/10/1
Re: MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy.
European Urology
2023/9/22
Laurence Klotz
H-Index: 55
The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis
Cardio Oncology
2023/2/1
Nazanin Aghel
H-Index: 4
Ian Brown
H-Index: 3
Laurence Klotz
H-Index: 55
Robert Sabbagh
H-Index: 10
Kelvin Kuan Huei Ng
H-Index: 13
The Use of PSMA PET/CT in a Prospective, Multicentre Registry for Patients with Recurrent Prostate Cancer–PREP Registry
Cureus Journal of Medical Science
2023/9/19
Re: Assessing “Spin” in Urology Randomized Controlled Trials With Statistically Nonsignificant Primary Outcomes. Letter
Journal of Urology
2023
Wilson Ho
H-Index: 4
Laurence Klotz
H-Index: 55
Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer
JAMA oncology
2023/1/1
